Global Vitiligo Therapeutics Market Report 2022-2026: Featuring Key Players Pfizer, Alkem Laboratories, Concord Biotech & Others - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Global Vitiligo Therapeutics Market 2022-2026" report has been added to ResearchAndMarkets.com's offering.
The publisher has been monitoring the vitiligo therapeutics market and it is poised to grow by $341.35 mn during 2022-2026, accelerating at a CAGR of 4.5% during the forecast period. The market is driven by the growing importance of aesthetic appeal, the dominance of OTC and off-label drugs providing volume growth, and a moderately competitive environment leading to demand-supply balance.
This study also identifies the growing disposable income in emerging countries as one of the prime reasons driving the vitiligo therapeutics market growth during the next few years. Also, pipeline boasting first-in-class drugs and the advent of regenerative medicines will lead to sizable demand in the market.
Key Topics Covered:
1 Executive Summary
2 Market Landscape
3 Market Sizing
3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
4 Five Forces Analysis
5 Market Segmentation by Route of Administration
5.1 Market segments
5.2 Comparison by Route of Administration
5.3 Topical - Market size and forecast 2021-2026
5.4 Oral - Market size and forecast 2021-2026
5.5 Others - Market size and forecast 2021-2026
5.6 Market opportunity by Route of Administration
6 Customer Landscape
6.1 Customer landscape overview
7 Geographic Landscape
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
8.4 Market trends
9 Vendor Landscape
9.2 Vendor landscape
9.3 Landscape disruption
9.4 Industry risks
10 Vendor Analysis
- Alkem Laboratories Ltd.
- AmerisourceBergen Corp.
- Astellas Pharma Inc.
- Bausch Health Companies Inc.
- Baxter International Inc.
- Biocon Ltd.
- Canixa Life Sciences
- Concord Biotech Ltd.
- Dr. Reddys Laboratories Ltd.
- Glenmark Pharmaceuticals Ltd.
- Intas Pharmaceuticals Ltd.
- La Pristine Bioceuticals Pvt. Ltd.
- LEO Pharma AS
- Mallinckrodt Plc
- Panacea Biotec Ltd.
- Pfizer Inc.
- Puneet Laboratories Pvt. Ltd.
- Sandoz International GmbH
- Strides Pharma Science Ltd
- Teva Pharmaceutical Industries Ltd.
- Veloxis Pharmaceuticals AS
- Viatris Inc.
For more information about this report visit https://www.researchandmarkets.com/r/e9y6l4
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900